연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1225 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Iwata, Hiroji | Iwata, H | 8 | Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan | AFO-7749-2022 | Iwata, Hiroji | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Yamashita, Toshinari | Yamashita, T | 9 | Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Layman, Rachel M. | Layman, RM | 10 | Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA | 0000-0002-8663-0331 | Layman, Rachel | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Mita, Monica | Mita, M | 11 | Hoag Family Canc Inst, Newport Beach, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Clay, Timothy | Clay, T | 12 | St John God Subiaco Hosp, Perth, WA, Australia | Y-4007-2019 | Clay, Timothy | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Chae, Yee Soo | Chae, YS | 13 | Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Daegu, South Korea | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Oakman, Catherine | Oakman, C | 14 | Sunshine Hosp, Western Hlth, St Albans, Vic, Australia | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Yan, Fengting | Yan, FT | 15 | Swedish Canc Inst, Hill True Family Womens Canc Ctr 1, Seattle, WA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Kim, Gun Min | Kim, GM | 16 | Yonsei Univ, Coll Med, Seoul, South Korea | ACI-8824-2022 | KANG, MIN KYU | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Im, Seock-Ah | Im, SA | 17 | Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea | J-5620-2012 | Im, Seock-Ah | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Lindeman, Geoffrey J. | Lindeman, GJ | 18 | Peter MacCallum Canc Ctr, Melbourne, Vic, Australia | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Lindeman, Geoffrey J. | Lindeman, GJ | 18 | Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Rugo, Hope S. | Rugo, HS | 19 | Univ Calif San Francisco, San Francisco, CA 94143 USA | NRX-7907-2025 | Rugo, Hope S. | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Liyanage, Marlon | Liyanage, M | 20 | Pfizer, San Diego, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Saul, Michelle | Saul, M | 21 | Pfizer, San Diego, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; |
페이지 이동: